AV COVID-19 vaccines may facilitate the formation of a pro-inflammatory and pro-thrombotic milieu in VITT, which supports the concept of raising plasma PF4 levels over a threshold to mount an anti-PF4 response (see Section “Platelet factor 4”). Here, PF4 is linked to COVID-19.